Transcenta Announces the Appointment of Dr. Caroline Germa as Executive Vice President, Global Medicine Development and Chief Medical Officer

/PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in...

Related Keywords

Guangzhou ,Guangdong ,China ,Shanghai ,Paris ,France General ,France ,Suzhou ,Jiangsu ,Boston ,Massachusetts ,United States ,Beijing ,Hangzhou ,Zhejiang ,Xueming Qian ,Los Angeles ,Caroline Germa ,Bristol Myers Squibb ,Clinical Development Centers ,Transcenta Holding ,Lille University ,Product Development Center ,Translational Research Center ,Novartis ,Group Headquarters ,Pfizer ,Prnewswire Transcenta Holding Limited ,Sanofi Aventis ,Astrazeneca ,Global Medicine Development ,Development Team ,Early Development Clinical Group ,Holding Limited ,Executive Vice President ,Chief Medical Officer ,Vice President ,Development Team Lead ,Eli Lilly France ,Medical Oncologist Degree ,Breast Disease ,Immunology Master Degrees ,Manufacturing Facility ,External Partnering Center ,Suzhou Industrial ,Transcenta Holding Limited ,